Alamar Biosciences Inc Asset Turnover Ratio (ALMR), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alamar Biosciences Inc   (ALMR)
 

Alamar Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Alamar Biosciences Inc 's asset turnover ratio sequentially decreased to 0.47 in the second quarter (Jun 30 2026), but remained above the company's average. For every Dollar on the Balance Sheet, Alamar Biosciences Inc realized $0.47 in annual sales.

Within sector Alamar Biosciences Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALMR Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change - - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.47 0.67 0.84 - -
ALMR's Total Ranking # # # # #
Seq. Asset Change 109.69 % 33.19 % - - -
Seq. Revenue Change 15.59 % 57.51 % 23.46 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




ALMR Company Profile • Back to ALMR Efficiency Comparisons • Compare ALMR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Globus Medical Inc   0.59 $ 3,144.934  Millions$ 5,331.554  Millions
Cvrx inc   0.59 $ 60.164  Millions$ 102.033  Millions
Skinhealth Systems Inc   0.59 $ 289.224  Millions$ 490.811  Millions
Radnet Inc   0.58 $ 2,268.932  Millions$ 3,883.896  Millions
Capsovision Inc   0.58 $ 12.804  Millions$ 22.085  Millions
Stereotaxis Inc   0.58 $ 29.892  Millions$ 51.863  Millions
Adaptive Biotechnologies Corporation  0.57 $ 308.081  Millions$ 537.492  Millions
Agilent Technologies inc   0.56 $ 7,372.000  Millions$ 13,121.500  Millions
Haemonetics Corporation  0.56 $ 1,351.722  Millions$ 2,413.607  Millions
Vsee Health Inc   0.56 $ 10.759  Millions$ 19.218  Millions
Intuitive Surgical Inc   0.56 $ 11,296.300  Millions$ 20,199.525  Millions
Vireo Growth Inc.  0.55 $ 511.706  Millions$ 924.643  Millions
Ceribell Inc   0.55 $ 101.804  Millions$ 184.939  Millions
Cormedix Inc   0.55 $ 451.943  Millions$ 824.173  Millions
Stryker Corp  0.55 $ 25,837.000  Millions$ 47,280.500  Millions
Transmedics Group Inc   0.54 $ 668.468  Millions$ 1,228.405  Millions
American Shared Hospital Services  0.54 $ 30.210  Millions$ 55.582  Millions
Integer Holdings Corporation  0.54 $ 1,842.621  Millions$ 3,410.801  Millions
Glaukos Corp  0.54 $ 500.031  Millions$ 926.678  Millions
Charles River Laboratories International inc   0.53 $ 3,998.987  Millions$ 7,477.922  Millions
Foxo Technologies Inc   0.53 $ 24.846  Millions$ 47.087  Millions
Rhythm Pharmaceuticals Inc   0.51 $ 239.918  Millions$ 466.663  Millions
Brookdale Senior Living Inc   0.51 $ 3,050.697  Millions$ 5,941.145  Millions
Merck and Co Inc   0.51 $ 66,569.000  Millions$ 131,224.750  Millions
Alkermes Plc   0.50 $ 1,667.652  Millions$ 3,366.927  Millions
Rapid Micro Biosystems Inc   0.49 $ 34.545  Millions$ 70.018  Millions
Johnson and Johnson  0.49 $ 97,929.000  Millions$ 198,495.250  Millions
Tenon Medical Inc   0.48 $ 5.312  Millions$ 10.971  Millions
Vertex Pharmaceuticals Inc  0.48 $ 12,587.200  Millions$ 26,103.250  Millions
Edwards Lifesciences Corporation  0.48 $ 6,512.500  Millions$ 13,539.425  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.